Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brazil sets new course, with medtech in wait

This article was originally published in Clinica

Executive Summary

Brazil's newly-elected president, Luiz Inacio Lula da Silva, inherits a country of great potential, not least to the healthcare industry, but burdened by huge social and economic problems. He has a hard act to follow with regard to what is widely regarded as the outgoing president's greatest legacy: public health. Under Fernando Henrique Cardoso, investments in healthcare have resulted in a significant improvement in services - it remains to be seen to what extent these can be maintained.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT068756

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel